The National Cancer Institute is offering a grant to enhance the development and validation of molecular diagnostics for cancer treatment and prevention. This grant focuses on validating prognostic, predictive, or response markers and markers for cancer control trials. Applicants should have assays that completed analytical validation in human samples with strong justification for clinical development. Projects may involve acquiring specimens from NCI-supported clinical trials. Collaboration among scientific investigators, clinicians, statisticians, and laboratory staff is essential. This grant aims to develop assays for potential clinical utility in cancer trials, observational studies, or populations. The deadline for applications is October 6, 2017.
Opportunity ID: 280479
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-16-056 |
| Funding Opportunity Title: | Revision Applications for Assay Validation For High Quality Markers For NCI-Supported Clinical Trials (U10) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 10, 2015 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Oct 06, 2017 |
| Current Closing Date for Applications: | Oct 06, 2017 |
| Archive Date: | Nov 06, 2017 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $150,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Public housing authorities/Indian housing authorities State governments Native American tribal governments (Federally recognized) Private institutions of higher education Small businesses Special district governments County governments Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to improve the development and validation of molecular diagnostics for the treatment, control, or prevention of cancer. This FOA includes, but is not limited to, the validation of prognostic, predictive or response markers for treatment and markers for cancer control or prevention trials. Applicants should have an assay that has essentially completed analytical validation in human samples and whose importance is well justified for development into a clinical assay. Analytical validation of assays for these markers should be sufficiently advanced when the application is submitted so that clinical validation may be achieved with little further analytical validation needed. Revisions may support acquisition of specimens from retrospective or prospective studies from NCI-supported or other clinical trials. Clinical laboratory staff, technical and other needs must be an integral part of the application. Assays proposed for this FOA may be used to validate existing assays for use in other cancer clinical trials, observational studies or populations. Projects proposed for this FOA require multi-disciplinary interaction and collaboration among scientific investigators, clinicians, statisticians and clinical laboratory scientists and staff. This FOA is not intended to support trials that assess the clinical utility of a marker/assay but is intended to develop assays to the point where their clinical utility could be assessed in other trials. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-16-056.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-C | FORMS-C | PKG00220073 | Jan 29, 2016 | Jun 16, 2016 | View | |
| FORMS-D | Use for due dates on or after May 25, 2016 | PKG00224407 | Jun 15, 2016 | Oct 06, 2017 | View |
Package 1
Mandatory forms
280479 RR_SF424_2_0-2.0.pdf
280479 PHS398_CoverPageSupplement_2_0-2.0.pdf
280479 RR_KeyPersonExpanded_2_0-2.0.pdf
280479 RR_OtherProjectInfo_1_3-1.3.pdf
280479 PerformanceSite_2_0-2.0.pdf
280479 PHS398_ResearchPlan_2_0-2.0.pdf
Optional forms
280479 PHS_Additional_IndirectCosts-1.0.pdf
Package 2
Mandatory forms
280479 RR_SF424_2_0-2.0.pdf
280479 PHS398_CoverPageSupplement_3_0-3.0.pdf
280479 RR_OtherProjectInfo_1_3-1.3.pdf
280479 PerformanceSite_2_0-2.0.pdf
280479 RR_KeyPersonExpanded_2_0-2.0.pdf
280479 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
280479 PHS_Additional_IndirectCosts-1.0.pdf
280479 PHS_AssignmentRequestForm-1.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
